Primary Hyperoxaluria

Disease State Hub

Featured

Conference Coverage
Conference Coverage
12/02/2025
Anthony Calabro, MA
Treatment with lumasiran improved kidney outcomes in patients with primary hyperoxaluria type 1, with no cases of end-stage kidney disease observed during follow-up in a study presented at Kidney Week....
12/02/2025
Conference Coverage
Conference Coverage
11/16/2025
Anthony Calabro, MA
In a qualitative study of physicians managing patients with primary hyperoxaluria type 1 (PH1), presented at Kidney Week 2025, clinicians emphasized simplicity, patient convenience, and ease of...
11/16/2025
Video
Video
06/28/2024
James Matera, DO
In this video, James Matera, DO, discusses the management of patients with primary hyperoxaluria (PH), including dietary modifications, hepatic and/or kidney transplantation, RNA interference agents,...
06/28/2024

Interactive Features

Poll
Poll
06/05/2024
Several medications are routinely used to treat individuals with primary hyperoxaluria. However, additional interventions have also been used to preserve kidney function and prevent kidney stone formation...
06/05/2024
pop quiz
pop quiz
02/13/2024
There are three types of primary hyperoxaluria, with type 1 being the most common. Do you know what percentage of cases of primary hyperoxaluria are type 1?
02/13/2024
pop quiz
pop quiz
01/12/2024
Are you familiar with the most common symptoms of this rare genetic disorder? Take this pop quiz to test your knowledge!
01/12/2024

Clinical Insights

Video
Video
06/28/2024
James Matera, DO
In this video, James Matera, DO, discusses the management of patients with primary hyperoxaluria (PH), including dietary modifications, hepatic and/or kidney transplantation, RNA interference agents,...
06/28/2024
Video
Video
06/26/2024
James Matera, DO
In this video, James Matera, DO, discusses an overview of primary hyperoxaluria (PH), including genetic screening, the etiology and progression to end-stage kidney disease, incidence, and diagnosis of PH...
06/26/2024